p53 Protein Overexpression: A Strong Prognostic Factor in Uterine Papillary Serous Carcinoma

Author： Bancher-Todesca D. Gitsch G. Williams K.E. Kohlberger P. Neunteufel W. Obermair A. Heinze G. Breitenecker G. Hacker N.F.

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.71, Iss.1, 1998-10, pp. : 59-63

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

p53 Overexpression and bcl-2 Persistence in Endometrial Carcinoma: Comparison of Papillary Serous and Endometrioid Subtypes

By Zheng W. Cao P. Zheng M. Kramer E.E. Godwin T.A.

Gynecologic Oncology, Vol. 61, Iss. 2, 1996-05 ,pp. : 167-174

Academic Press

Access to resources Recommend Favorite

p27 and Cyclin D1 Abnormalities in Uterine Papillary Serous Carcinoma

By Schmitz M.J. Hendricks D.T. Farley J. Taylor R.R. Geradts J. Rose G.S. Birrer M.J.

Gynecologic Oncology, Vol. 77, Iss. 3, 2000-06 ,pp. : 439-445

Elsevier

Access to resources Recommend Favorite

Evaluation of a Region on Chromosome 1p in Ovarian Serous Carcinoma That Is Frequently Deleted in Uterine Papillary Serous Carcinoma

By Herzog T.J. Kowalski L.D. Liu H. Arlt M. Swisher E.

Gynecologic Oncology, Vol. 82, Iss. 1, 2001-07 ,pp. : 139-142

Elsevier

Access to resources Recommend Favorite

Treatment of Uterine Papillary Serous Carcinoma with Paclitaxel

By Ramondetta L. Burke T.W. Levenback C. Bevers M. Bodurka-Bevers D. Gershenson D.M.

Gynecologic Oncology, Vol. 82, Iss. 1, 2001-07 ,pp. : 156-161

Elsevier

Access to resources Recommend Favorite

Neoadjuvant Chemotherapy in Uterine Papillary Serous Carcinoma

By Resnik E. Taxy J.B.

Gynecologic Oncology, Vol. 62, Iss. 1, 1996-07 ,pp. : 123-127

Academic Press

Access to resources Recommend Favorite